ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PRAX Praxis Precision Medicines Inc

46.89
0.30 (0.64%)
After Hours
Last Updated: 16:03:56
Delayed by 15 minutes

Period:

Draw Mode:

Volume 350,085
Bid Price 45.97
Ask Price 47.81
News -
Day High 48.185

Low
12.45

52 Week Range

High
67.21

Day Low 45.596
Company Name Stock Ticker Symbol Market Type
Praxis Precision Medicines Inc PRAX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.30 0.64% 46.89 16:03:56
Open Price Low Price High Price Close Price Prev Close
46.59 45.596 48.185 46.89 46.59
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,213 350,085 $ 46.85 $ 16,401,331 - 12.45 - 67.21
Last Trade Time Type Quantity Stock Price Currency
16:25:56 4 $ 47.81 USD

Praxis Precision Medicines Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
632.13M 13.24M - 2.45M -123.28M -9.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Praxis Precision Medicines News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PRAX Message Board. Create One! See More Posts on PRAX Message Board See More Message Board Posts

Historical PRAX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week53.5956.5845.59651.09170,058-6.70-12.50%
1 Month53.7667.2145.59656.80335,191-6.87-12.78%
3 Months36.9967.2136.0153.14192,7819.9026.76%
6 Months18.4567.2113.00533.04246,09628.44154.15%
1 Year15.9067.2112.4521.48629,03530.99194.91%
3 Years405.60489.0011.8561.69783,508-358.71-88.44%
5 Years408.15914.257511.8586.16704,469-361.26-88.51%

Praxis Precision Medicines Description

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

Your Recent History

Delayed Upgrade Clock